| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NG
|
1,180.50 | 59.3B | 18.31 | 1.51 | 13.09 | 6.3% | 8.5% | 54 | 37 | 1,172.00 | -0.5% | 50 | 1.19 |
|
UU
|
1,418.00 | 10.5B | 17.95 | 4.70 | 12.08 | 8.7% | 7.9% | 54 | 36 | 1,095.76 | -15.2% | 52 | 5.12 |
|
SSE
|
2,385.00 | 28.8B | 23.80 | 1.84 | 11.96 | 7.7% | 10.7% | 49 | 32 | 2,066.18 | -9.6% | 63 | 0.65 |
|
SVT
|
3,070.00 | 9.3B | 40.42 | 5.24 | 15.54 | 5.3% | 9.2% | 36 | 25 | 1,549.37 | -35.7% | 41 | 5.48 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.